Dr. Prerana Jain Roth, MD

Dr. Roth practices at Prisma Health Greenville Memorial Hospital in Greenville, South Carolina, part of Prisma Health.

Dr. Roth's NPI, 1548434863, was assigned on April 17, 2008. Dr. Roth graduated from Northwestern University Feinberg Medical School in 2008. Dr. Roth holds South Carolina license 36564.

Dr. Roth's primary practice is Prisma Health Greenville Memorial Hospital, at 701 Grove Road, Greenville, SC 29605 in Greenville County. The practice phone is (864) 455-7000.

Dr. Roth's primary practice is Prisma Health Greenville Memorial Hospital in Greenville, South Carolina, part of Prisma Health. Dr. Roth is also affiliated with Bon Secours St. Francis Downtown. The medical group on file is Prisma Health Medical Group. Dmand AI also links Dr. Roth to 2 more hospitals, 4 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Roth practices, 7 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Roth's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Roth is licensed in South Carolina.

CMS data shows 143 Medicare services from Dr. Roth across 3 procedure codes in 2024, for 117 Medicare patients. Medicare paid $10,780 for them.

CMS counts 117 Medicare patients who saw Dr. Roth in 2024. The largest group is 75 to 84, with 47 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Roth's median patient age at 58, with 43% women.

In 2024, Dr. Roth wrote 1,194 Medicare Part D claims for 240 patients. 37% of them were for generic drugs. CMS names the drug for 907 of them, across 24 drugs with 11 or more claims each, at $3,060,118 in total drug cost. In 2023, CMS named 1,267 claims across 34 drugs.

Dr. Roth accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Roth as offering telehealth.

Dmand AI links 23 papers to Dr. Roth, published from 2014 to 2025. 2022 was the busiest year, with 4. The most frequent topics are Inpatients, Opiate Substitution Treatment and Opioid-Related Disorders. Dr. Roth has published most often in Clin Pract Cases Emerg Med. Dr. Roth's most frequent co-authors are Meredith A. Schade, MD, Matthew Jiro Akiyama, MD and Nina M. Clark.

CMS Open Payments shows 119 general payments to Dr. Roth from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Gilead Sciences, Inc. paid the most, $459.

Dr. Roth graduated from Northwestern University Feinberg Medical School in 2008.